0001829522-22-000001.txt : 20220426 0001829522-22-000001.hdr.sgml : 20220426 20220425190107 ACCESSION NUMBER: 0001829522-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220426 DATE AS OF CHANGE: 20220425 EFFECTIVENESS DATE: 20220426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Antlia Bioscience, Inc. CENTRAL INDEX KEY: 0001829522 IRS NUMBER: 844808002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-443291 FILM NUMBER: 22851181 BUSINESS ADDRESS: STREET 1: 1281 HYMETTUS AVE CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: 619-990-0290 MAIL ADDRESS: STREET 1: 1281 HYMETTUS AVE CITY: ENCINITAS STATE: CA ZIP: 92024 D 1 primary_doc.xml X0708 D LIVE 0001829522 Antlia Bioscience, Inc. 1281 HYMETTUS AVE ENCINITAS CA CALIFORNIA 92024 619-990-0290 DELAWARE None None Corporation true 2020 Brian Laurence Johnson 1281 Hymettus Ave. Encinitas CA CALIFORNIA 92024 Executive Officer Director Other Technology Decline to Disclose 06b false 2022-04-13 false true true false 0 2500000 680000 1820000 false 10 0 0 0 The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes. false Antlia Bioscience, Inc. Brian Laurence Johnson Brian Laurence Johnson Chief Executive Officer 2022-04-25